Skin Glues Compared to Running Sutures for Perineal Skin Repair After Vaginal Delivery. A Randomized Controlled Trial
Launched by HAEMEK MEDICAL CENTER, ISRAEL · Jun 10, 2019
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether using skin glue is a better option than traditional stitches for repairing minor perineal tears (grade 1 and 2) and episiotomies after vaginal delivery. The goal is to see if the glue method can speed up the healing process and reduce pain while still keeping the risk of complications, like infection or bleeding, similar to that of stitches.
Women aged 18 to 45 who have given birth at term (after 37 weeks) and have a minor perineal tear or episiotomy may be eligible to participate. Participants will have the chance to experience a potentially quicker and less painful repair method. It’s important to note that women with more severe perineal tears (grades 3 or 4), certain health issues, or signs of infection before repair will not be included in the trial. If you join, you will be contributing to valuable research that could help improve recovery for many women in the future.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 1. Women aged 18-45.
- • 2. Term birth (\> 37.0 weeks).
- • 3. Perineal tears grade 1 or 2, or episiotomy.
- Exclusion Criteria:
- • 1. Perineal tears grades 3 or 4.
- • 2. Operative vaginal deliveries.
- • 3. Significant background diseases that can affect pain or recovery time: Pregestational diabetes mellitus, any heart disease, severe pulmonary disease, collagen or connective tissue disease, rheumatic diseases, autoimmune diseases, known immunodeficiency and chronic steroid use.
- • 4. Signs of local infection prior to the beginning of repair of the tear.
- • 5. Known allergy to exofin®.
- • 6. Pregestational body mass index \> 35 kg/m2.
- • 7. Women with excessive bleeding that does not allow the use of glue.
- • 8. Delivery of a dead fetus.
About Haemek Medical Center, Israel
Haemek Medical Center, located in Israel, is a leading healthcare institution renowned for its commitment to advancing medical research and patient care. With a strong emphasis on clinical trials, the center collaborates with multidisciplinary teams to explore innovative treatments and therapies across various medical fields. Haemek Medical Center is dedicated to maintaining high ethical standards and regulatory compliance, ensuring the safety and well-being of participants while contributing valuable insights to the global medical community. Through its robust research programs and state-of-the-art facilities, the center aims to enhance healthcare outcomes and foster scientific advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Afula, , Israel
Patients applied
Trial Officials
Raed Salim, MD
Study Chair
Emek Medical Center, Afula, Israel
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials